New Ebola Vaccine, Drug Trials to Start in West Africa

Scientists will start the first large-scale tests of Ebola vaccine, one developed in the USA and one developed in Canada, on people in West Africa within a few weeks, announced U.S. authorities on Thursday.

Anthony Fauci, director of the National Institute of Allergy and Infectious Disease said that scientists at the National Institutes of Health (NIH) would partner with the Liberian government to launch a clinical trial of two vaccines.

Ebola Virus Disease | Ebola Hemorrhagic Fever: Cause Symptoms Diagnosis Treatment
Ebola is caused by a virus via direct contact with body fluids or infected blood. Scientists have identified five types of Ebola or Ebola hemorrhagic fever virus.

The Sierra Leone government will work with researchers at the Centers for Disease Control and Prevention to test one of the vaccines.

Scientists at the Centers for Disease Control and Prevention will work with the government of Sierra Leone to test one of the vaccines.

An effective Ebola vaccine could help to control the current outbreak and could be lifesaving in future outbreaks.

Beyond vaccines, NIH doctors will work with Liberia to test the experimental treatment drug Zmapp. The drug has been given to several Ebola patients but has never been formally tested in humans, officials say. The studies will be conducted in the USA and Liberia.

According to the World Health Organization, Ebola has infected 21,759 people and killed 8,668, primarily in Guinea, Liberia and Sierra Leone.

Ebola: Sierra Leone Lifts Quarantines as Crisis Eases
Sierra Leone on Friday lifted crippling nationwide restrictions on movement put in place at the height of the Ebola crisis, amid signs that the deadly epidemic is retreating.

Source-Medindia

Sierra Leone Ends 'Risk Allowance' for Ebola Health Workers
Sierra Leone will stop paying the 'risk allowances' it has been paying to thousands of healthcare workers on the front line of its battle with Ebola.